BAILEY WILSON: Open Payments
NPI 1558098558 · VINEYARD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 10 companies in 2025. Trend: 2023 $360 · 2024 $523 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $252 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $26 |
| ViiV Healthcare Company | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Corium, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: QULIPTA, VRAYLAR, UBRELVY, MOUNJARO, Ozempic, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, APRETUDE, SPRAVATO.
Industry payments across UT — which companies pay providers there.
